BAP Stock Analysis: Credicorp | NYSE
Banks - Regional | NYSE, USA | Market Cap: 29.402m USD | 12M Return: 58.2% | BMG2519Y1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 103M
EPS Trend: 95.7%
Qual. Beats: 0
Rev. Trend: 88.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Credicorp Ltd. (NYSE: BAP) is a Lima, Peru-based financial holding company founded in 1889 that operates across Peru, Bermuda, Colombia, Bolivia, Panama, Chile, the United States, the Cayman Islands, and Mexico. It runs four business segments: Universal Banking; Insurance, Medical Services, and Pensions; Microfinance; and Investment Management and Advisory. Its activities span credit and deposit products for individuals and legal entities, insurance underwriting (commercial property, transport, marine, automotive, life, health, and pensions), private pension fund administration, brokerage and investment management for institutional and corporate clients, capital markets and securitization services, custody and trustee services, asset management, payment processing, and digital commerce platforms.
As a Diversified Bank within the GICS Financials sector, Credicorp combines traditional commercial banking with insurance, pensions, and microfinance under a universal banking model. Listed on the NYSE since 1995, it is considered the largest financial group in Peru, with a presence that extends across much of the Andean and broader Latin American region.
- Peru central bank rate cuts compress net interest margin
- Universal Banking loan growth drives segment revenue
- Insurance and pension AUM growth lifts fee income
| Net Income: 7.34b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.48 > 1.0 |
| NWC/Revenue: 85.45% < 20% (prev -334.6%; Δ 420.1% < -1%) |
| CFO/TA 0.02 > 3% & CFO 5.65b > Net Income 7.34b |
| Net Debt (-4.59b) to EBITDA (11.7b): -0.39 < 3 |
| Current Ratio: 2.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.4m) vs 12m ago -0.61% < -2% |
| Gross Margin: 76.74% > 18% (prev 63.04%; Δ 13.70% > 0.5%) |
| Asset Turnover: 11.08% > 50% (prev 10.50%; Δ 0.58% > 0%) |
| Interest Coverage Ratio: 2.23 > 6 (EBIT TTM 10.8b / Interest Expense TTM 4.84b) |
| A: 0.09 (Total Current Assets 43.5b - Total Current Liabilities 18.3b) / Total Assets 282b |
| B: 0.01 (Retained Earnings 4.08b / Total Assets 282b) |
| C: 0.04 (EBIT TTM 10.8b / Avg Total Assets 266b) |
| D: 0.16 (Book Value of Equity 38.1b / Total Liabilities 244b) |
| Altman-Z'' = 1.07 = BB |
| DSRI: 0.16 (Receivables 2.27b/12.3b, Revenue 29.4b/26.1b) |
| GMI: 0.82 (GM 63.04% / 76.74%) |
| AQI: 1.25 (AQ_t 0.84 / AQ_t-1 0.67) |
| SGI: 1.13 (Revenue 29.4b / 26.1b) |
| TATA: 0.01 (NI 7.34b - CFO 5.65b) / TA 282b) |
| Beneish M = -3.64 (Cap -4..+1) = AAA |
As of August 22, 2026, the stock is trading at USD 378.97 with a total of 170,185 shares traded. Over the past week, the price has changed by -1.91%, over one month by -3.10%, over three months by +10.17% and over the past year by +58.20%.
Current recommended Stop Loss: 362.40 (which is 4.4% or 1.3 ATR below the current price).
Credicorp has received a consensus analysts rating of 4.23. Therefore, it is recommended to buy BAP.
- StrongBuy: 7
- Buy: 3
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 422.8 | 11.6% |
P/E Trailing = 13.6811
P/E Forward = 12.6422
P/S = 1.3204
P/B = 2.6408
P/EG = 4.5503
Revenue TTM = 29.4b USD
EBIT TTM = 10.8b USD
EBITDA TTM = 11.7b USD
Long Term Debt = 24.7b USD (from longTermDebt, last fiscal year)
Short Term Debt = 18.3b USD (from shortTermDebt, last quarter)
Debt = 36.6b USD (from shortLongTermDebtTotal, last quarter) + Leases 612.3m
Net Debt = -4.59b USD (calculated: Debt 36.6b - CCE 41.2b)
Enterprise Value = 24.8b USD (29.4b + Debt 36.6b - CCE 41.2b)
Interest Coverage Ratio = 2.23 (Ebit TTM 10.8b / Interest Expense TTM 4.84b)
EV/FCF = 4.62x (Enterprise Value 24.8b / FCF TTM 5.37b)
FCF Yield = 21.65% (FCF TTM 5.37b / Enterprise Value 24.8b)
FCF Margin = 18.24% (FCF TTM 5.37b / Revenue TTM 29.4b)
Net Margin = 24.93% (Net Income TTM 7.34b / Revenue TTM 29.4b)
Gross Margin = 76.74% ((Revenue TTM 29.4b - Cost of Revenue TTM 6.85b) / Revenue TTM)
Gross Margin QoQ = 74.92% (prev 77.66%)
Tobins Q-Ratio = 0.09 (Enterprise Value 24.8b / Total Assets 282b)
Interest Expense / Debt = 13.21% (Interest Expense 4.84b / Debt 36.6b)
Taxrate = 29.09% (3.07b / 10.6b)
NOPAT = 7.65b (EBIT 10.8b * (1 - 29.09%))
Current Ratio = 2.37 (Total Current Assets 43.5b / Total Current Liabilities 18.3b)
Debt / Equity = 0.96 (Debt 36.6b / totalStockholderEquity, last quarter 38.1b)
Debt / EBITDA = -0.39 (Net Debt -4.59b / EBITDA 11.7b)
Debt / FCF = -0.86 (Net Debt -4.59b / FCF TTM 5.37b)
Total Stockholder Equity = 37.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.76% (Net Income 7.34b / Total Assets 282b)
RoE = 19.58% (Net Income TTM 7.34b / Total Stockholder Equity 37.5b)
RoCE = 17.33% (EBIT 10.8b / Capital Employed (Equity 37.5b + L.T.Debt 24.7b))
RoIC = 2.72% (NOPAT 7.65b / Invested Capital 281b)
WACC = 8.64% (E(29.4b)/V(66.0b) * Re(7.73%) + D(36.6b)/V(66.0b) * Rd(13.21%) * (1-Tc(0.29)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 21.50 | Cagr: -0.03%
[DCF] Terminal Value 72.03% ; FCFF base≈8.59b ; Y1≈7.53b ; Y5≈6.08b
[DCF] Fair Price = 1.23k (EV 93.2b - Net Debt -4.59b = Equity 97.8b / Shares 79.4m; r=8.64% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 95.74 | EPS CAGR: 22.56% | SUE: 0.19 | # QB: 0
Revenue Correlation: 88.20 | Revenue CAGR: 7.21% | SUE: 0.82 | # QB: 0
EPS current Quarter (2026-09-30): EPS=7.39 | Chg30d=-0.19% | Revisions=-25% | Analysts=4
EPS current Year (2026-12-31): EPS=29.73 | Chg30d=+0.18% | Revisions=+17% | GrowthEPS=+14.9% | GrowthRev=+11.7%
EPS next Year (2027-12-31): EPS=34.15 | Chg30d=+0.73% | Revisions=+50% | GrowthEPS=+14.9% | GrowthRev=+10.5%
[Analyst] Revisions Ratio: +30% (up=5, down=2)